key: cord-0056588-hkhq123v
authors: Rehman, Zaira; Fahim, Ammad; Bhatti, Muhammad Faraz
title: Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition
date: 2021-02-22
journal: nan
DOI: 10.2217/fvl-2020-0269
sha: ce022697ec11b706a5d3e92ad8c3d81c5e7209bc
doc_id: 56588
cord_uid: hkhq123v

Aim: December 2019 witnessed the emergence of a worldwide outbreak of a novel strain of coronavirus (CoV) termed SARS-CoV-2. Several preventive strategies are being developed, such as vaccines, to stop the spread of infection. Materials & methods: A comprehensive immunoinformatics approach was used to map conserved peptide sequences on the receptor binding domain of SARS-CoV-2 for their B-cell, T-helper & T-cytotoxic cell epitope profiles. Results & conclusion: The antigenic B-cell epitopes were LFRKSN and SYGFQPT. Among T-cell epitopes, CVADYSVLY and FTNVYADSF exhibited affinity for MHC class I, while YRLFRKSNL and VYAWNRKRI exhibited affinity for of MHC class II alleles. The overlapping epitope between B- and T-cells was YRLFRKSNL. The deployment of these epitopes in potential vaccine development against COVID-19 may help in slowing down the SARS-CoV-2 spread.

epitope prediction methods. Kolaskar & Tongaonkar method predicted antigenicity on the basis of amino acid abundances in naturally occurring epitopes as well as their physicochemical properties. The default threshold was set to 1.00 for antigenicity determination [60] . Emini surface accessibility method predicts the surface accessibility of epitopes as the surface accessible peptides recognized by the immune system [61] . Chou & Fasman beta-turn method was used to predict the antigenic regions, exhibiting beta turn as the beta turns are usually hydrophilic in nature and highly accessible [62] . Karplus & Schulz flexibility method predicts those antigens that are exhibiting flexible amino acids in nature as flexibility is correlated with antigenicity [63] . BepiPred prediction method based on hidden Markov model predicts linear epitopes in protein [64] . The B-cell epitopes were also predicted using ElliPro, which identifies linear and discontinuous epitopes in protein structure. It calculates the protrusion index (PI) of the residues and then cluster the residues on the basis of protrusion index values [65] .

For vaccine development, cytotoxic T-lymphocyte (CTL) epitopes play an important role. Hence the T-cell epitopes were identified that have the ability to bind with MHC class I (MHC-I) and class II (MHC-II). CTL epitopes were identified through NetCTL 1.2 server. It is based on artificial neural network and trained on different human MHC alleles for prediction of epitopes [66] . The IEDB and NetMHCI 4.0 server were used to predict the binding of epitopes with MHC-I. NetMHCI 4.0 predicts the binding affinity through artificial neural network by schooling 81 distinct HLA-A, -B, -C and -E human MHC alleles [67] . T-helper cell epitopes were predicted through IEDB and NetMHCII 2.3 server [68] . The epitopes were predicted having high affinity toward HLA-DR, -DQ and -DP. The length of the predicted epitopes was set to be 9-mer epitopes as it is reported that most HLA molecules have a strong preference for binding 9-mer epitopes [33] . For all the T-cell epitopes the threshold for predicting the binding affinity was set to ≤500 nM.

B-& T-cell epitopes feature profiling B-and T-cell epitopes were further scrutinized for their enzymatic digestion, toxicity, hydrophobicity and physiochemical properties. The digestion of peptides with enzymes is an important parameter in vaccine development as the peptides that are digested by many enzymes are usually rendered unstable. Hence, the digestion of peptides by different enzymes was predicted through protein-digest server. AntiangioPred was used to predict the mutational variability and other physicochemical properties of peptides. It is based on machine learning model that is generated on the basis of already reported anti-angiogenic peptide [69] . ClanTOX predicted toxicity of peptides [70] . It is trained on set of ion-channel inhibitors and a set of nontoxin proteins. Based on the model, the program predicts the toxicity of input peptide. Antigenicity of peptides was predicted through Immunomedicine group server. For a peptide to be antigenic the threshold is 1.0. Antigenic prediction is based on physicochemical properties of epitopes like hydrophilicity, flexibility and accessibility [60] .

Human proteome analysis for nonhuman homologues To avert autoimmunity, vaccine contenders were screened for human and nonhuman homologues. The nonhuman homologues were identified by scrutinizing selected epitopes sharing <30% identity with human proteome, via BLASTp analysis.

The peptides that showed affinity for maximum number of MHC-I and MHC-II alleles were selected for interaction analysis. The structure of peptides was modeled through PEPFOLD server [71] followed by energy minimization. In case of MHC-I, the common allele between the peptides was selected for docking. Hence, the crystal structure of human HLA-A*0101 was downloaded from Protein Databank (PDB; PDB ID: 6AT9: resolution = 2.9Å). Same criterion was followed for MHC-II alleles and for that the crystal structure of HLA-DRB5*01:01 (PDB ID: 1FV1: resolution = 1.9Å) was also downloaded from PDB. Both the structures after ligand removal underwent protonation followed by energy minimization by AMBER99 force field. In order to analyze the inhibitory potential of peptides the docking of MHC-I specific peptides was executed with the HLA-A*0101 alleles, while the MHC-II specific peptides were docked with HLA-DRB5 0101. The docking studies were accomplished with induced fit docking protocol implemented in molecular operating environment (MOE) version 2016.08. By using, triangle match as placement method with London-dG scoring and GBVI/WSA dG rescoring function, 50 poses of each peptide were generated. Interaction analysis was done using MOE and PyMOL v2.3.

After identification of vaccine epitopes, we further explored whether these vaccine epitopes harbor any important residues that could be involved in binding of SARS-CoV-2 with human ACE2 (hACE2) and BatCoV RaTG13 with bat ACE2 (bACE2). The interactions of SARS-CoV-2 with hACE2 were recently reported by Lan et al [72] . The interaction analysis of BatCoV RaTG13 with bACE2 was performed in the current study. To the best of our knowledge, the structure of RBD of BatCoV RaTG13 as well as bACE2 has not been determined yet. Hence the structure of both the proteins was determined through homology modeling using Modeller V9.23. BatCoV RaTG13 was modeled using SARS-CoV as template (PDB ID: 2GHV). While bACE2 was modeled using hACE (PDB ID: 1R42) as template. The generated model was subjected to model evaluation and structural validation via Ramachandran plot, PROSA, ERRAT, QMEAN and MolProbity. Ramachandran plot calculates the presence of amino acid residues in allowed, favored and outlier regions on the basis of torsional angles ( and ) of amino acids [73] . PROSA reveal the quality of model by estimating any error in the models. It also calculates the score of model on the basis of experimentally reported (x-ray and nuclear magnetic resonance) structures of proteins [74] . Qualitative model energy analysis (QMEAN) apprises the geometry of protein structure by measuring the torsion angles on three consecutive amino acid residues [75] . MolProbity evaluates the protein structure by assessing its geometry [76] . ERRAT gauged the quality of model by analyzing the statistics between nonbonded interactions and different type of atoms and compared these values with the extremely refined structures [77] . The best model was then subjected to energy minimization using AMBER99 force field implemented in MOE. Docking of BatCoV RaTG13:bACE2 was performed using HADDOCK web server [78] . Analysis of protein-protein interactions was performed through pdbSum [79] and PyMOL v2.3.

Multiple sequence alignment RBD of SARS-CoV-2 is 192 amino acids long (within position 330-522 amino acids) lying in S1 region of S glycoprotein. When comparing the receptor binding motif with the BatCoV RaTG13 there was variation between the two virus strains (Supplementary Figure 1 B-cell epitopes within RBD Continuous B-cell epitopes were predicted using B-cell epitope prediction methods on IEDB server. The Kolaskar & Tongaonkar method predicted 11 antigenic epitopes in the RBD (Table 1) , which can prompt B-cell responses. Surface accessibility analysis revealed four epitopes with surface accessibility ( Table 1 ). Flexibility of epitopes is a measure of antigenicity [53] Cytotoxic T-cell epitope prediction The default setting in the NetCTL server was used to predict T-cell epitopes. On the basis of highest combinatorial scores, five epitopes (with NetCTL score = 1.1-2.5 nM) were opted for subsequent analysis (Table 2) Helper T-cell epitope prediction A total of nine peptides were predicted which exhibited strong affinity for MHC-II alleles ( 

To identify the best epitope for vaccine construction, different features of T-cell epitopes were determined ( Table 3) . The identified epitopes did not exhibit any homology with human proteins, were conserved and predicted to be nontoxic. The peptides which were digested by fewer enzymes have been considered good potential vaccine candidates ( Table 3) . Antigenicity of the peptides depicted that CTL specific peptides can be antigenic except the peptide ERDISTEIY. In case of helper T-cell epitopes, FELLHAPAT, TGCVIAWNS and VLYNSASFS were highly antigenic. In case of B-cell epitopes, all the three peptides were antigenic.

Two peptides (CVADYSVLY and FTNVYADSF) with the maximum number of bindings with HLA alleles were selected for interaction analysis. PEPFOLD created five models for each peptide and the model with the best score was selected for further analysis. HLA-A*0101 was selected as representative allele for interaction analysis. The docking of HLA-A with the top ranking peptide resulted in generation of 50 complexes for each peptide. The peptide 3 (CVADYSVLY) binds with HLA with binding energy of -11.3 KJ/mol, while a detailed interaction analysis revealed that peptide had H-bonding interactions with Asp-115, Arg-156, Tyr-99 and Asn-77 ( Figure 2A ). Figure 2D ).

The interactions of BatCoV RaTG13 with bACE2 were done using HADDOCK. There were 155 different complexes of BatCoV RaTG13:bACE2 that were generated, which clustered into 12 groups. Supplementary Table  1 shows the Z scores of all the seven clusters, size of each cluster, root-mean-square deviation (RMSD) from the overall lowest energy structure, and energy values of electrostatic, Van der Waals, and desolvation. The cluster with the best HADDOCK score (-178.9 ± 3.6) was further used for analysis. Detailed interaction analysis showed that 26 residues of bACE2 and nine residues of BatCoV RaTG13 were present at the interface. These residues were involved in 12 H-bonded, two salt bridges and 157 nonbonded contacts. The detailed interactions are shown in Table 4 and Figure 3 . 

Research on various CoV species earlier has been continually reported since the last one and a half decade after the emergence of SARS, for annotating signatures and virulence factors [80] . Viral entry receptors are crucial in viral life cycle, sustenance and egress [81] . Realizing their particular tissue tropism further augments their importance for therapeutic targeting and restricting viral entry into cell which can abolish infectivity altogether. In case of SARS-CoV and MERS-CoV, S protein and specially S1 regions have been the prime focus in developing immune strategies against these strains [52] . Similar strategy can be employed by investigating the S protein for identifying immune epitopes against SARS-COV-2. Vaccines against SARS-CoV-2 can serve as one of the most promising modes of containing COVID-19 pandemic. To date no reliable treatment options are available for COVID-19, so logically vaccine against it is a much needed solution. As the global burden of infectivity by COVID-19 pandemic is increasing every day, computational biology aided vaccine design for SARS-CoV-2 with removal of unnecessary antigenic load and screened allergic response can provide the characteristic immune response required for preventing SARS-CoV-2 infection. Similar to SARS-CoV and MERS-CoV, S1 region of CVOID-19 harbors the RBD which is involved in the entry of virus into a host cell. Hence, the identification of antigenic peptides within RBD can be a good strategy to forestall infection. The present study focused on deriving immunogenic epitopes capable of triggering both humoral and cell mediated immune response, on the basis of high degree of comparative sequence similarity of RBD from BatCoV RaTG13 with SARS-CoV-2. Previously, immunogenic epitopes for SARS-CoV-2 by immunoinformatics method have been reported in comparison with SARS-CoV [23] [24] [25] . Using this approach may yield rather specific epitopes against SARS-CoV-2. Contextually, cross-reactivity of SARS-CoV antibodies against SARS-CoV-2 epitopes is also under debate and is providing useful information against potential SARS-CoV-2 host immune response [17, 31, 32] . Current results from analysis of RBD of SARS-CoV-2 revealed that 423-YKLPDD-428, 455-LFRKSN-461 and 494-SYGFQPT-500 are the B-cell epitopes that are highly antigenic. The two epitopes lie in receptor binding motif and also muddled in interactions with hACE2 [72] . The Leu-455, Phe-456, Ser-494 and Thr-500 were the conserved residues among all the SARS-CoV-2 sequences hooked in interactions with hACE2. In case of T-cell epitopes, several epitopes were identified from IEDB and NetCTL and the peptides manifesting affinity with maximum number of MHC-I/MHC-II alleles were further selected for analysis. Previously, it has been reported that peptides showing affinity with maximum number of HLA alleles could be very antigenic [53, 54] . In case of CTL epitopes, two epitopes (peptide 3: CVADYSVLY and peptide 4: FTNVYADSF) were found to be highly antigenic and also showed strong binding with HLA-A allele. HLA are polymorphic proteins with variable expression in different population. Therefore, a vaccine which is suited for all population without inciting any autoimmunity met by for T-cell epitopes by HLA selectivity is crucial for an effective vaccine candidate [82] [84] . When we studied peptide 5 (YRLFRKSNL), Asn-62, Arg-71 and Glu-55 were residues important for binding of peptide. In case of peptide 6 (VYAWNRKRI), the Ser-53, Asp-11 and Asp-70 were involved in interactions with peptide. The interaction as well as binding energy data depicted these two peptides to be binding with HLA-DRB5 and can be used in vaccine construction. The peptide 453-YRLFRKSNL-461, present within the receptor binding motif and Leu-455 and Phe-456 illustrated interactions with hACE2 [72] as well as bACE2.

On the basis of different properties of these selected B-and T-cell epitopes, it can be observed that these epitopes were 100% conserved from the reported data, as predicted by conservation analysis. These peptides also did not exhibited homology with any human protein hence may not incite any autoimmunity. These peptides did not display any toxicity. The digesting enzyme data showed these peptides to be indigestible by a range of enzymes and hence are safer to use for vaccine development ( Table 3 ). The B-and T-cell epitopes (LFRKSN and YRLFRKSNL) are overlapping, hence the presence of YRLFRKSNL in vaccine construct along with other peptides may enhance the efficacy of a vaccine. The analysis on the sequences submitted until October 2020 has shown that all the predicted epitopes have been fairly conserved except one change observed in T-cell epitope (453-YRLFRKSNL-461) region at position 453 as Y453F. This mutation was labeled as mink mutation and found in SARS-CoV-2 sequences obtained from Denmark, South Africa and The Netherlands [85, 86] . The results proposed herein are preliminary and further in vitro and in vivo testing is required for the proposed vaccinable targets of SARS-CoV-2. Based on the study results, the predicted epitopes harbor attractive capability to be considered for ascertaining therapeutic potency. The identified epitopes from this study can further be investigated along with conserved region epitopes of S protein for molecular simulation studies, in construction of experimental vaccine constructs and for considering its potential as a peptide based vaccine.

Cumulatively, the detailed interaction analysis of BatCoV RaTG13 has shown that hydrophobic and charged residues have been involved in binding with bACE2. Analogous pattern has been observed in binding of SARS-CoV-2 with hACE2 receptor [72] . The important residues of BatCoV RaTG13 that were involved in interactions with bACE2 are Lys-417, Leu-455, Phe-456, Asn-487, Tyr-489, Asp-501 and His-505. The residues at these positions in SARS-CoV-2 were also involved in interactions with hACE2 [72] . Among them Lys-417, Leu-455, Phe-456, Asn-487 and Tyr-489 were the conserved residues ( Figure 4) .

Designing an effective vaccine against viral infection such as COVID-19 is tricky. On one hand, it has to be ensured that the vaccinable epitopes hold enough antigenic potential to mount a befitting yet specific immune response so as to rapidly clear the infection if the need arises; on the other hand, the host immune response should not be strong enough to trigger chronic inflammation which in case of COVID-19 might significantly deteriorate lung infection. Lung as an organ is highly sensitive to inflammatory changes initiated by a surge of cytokine response [87] . Mutations in the viral genome are capacitating CoVs to breach species barrier repeatedly. As the CoVs harbor an error-prone RNA dependent-RNA polymerase, it may engender recombination events with mutational diversity, concocting therapeutic challenges and survival advantage to the virus [80] . This has been the case observed in SARS-CoV epidemic of 2004 [88, 89] . It is of grave concern that SARS-CoV-2 has the potential to reach pandemic proportions while considering the low persistent R o estimates. As bats are considered primary hosts for CoV species, it will be interesting to scrutinize how bats evade viral entry as previous studies have identified bats evolving a mechanism for defying interferon pathway activation by the STING interferon pathway [90] .

The current study proposed the identification of potential multiple epitopes for vaccine development against SARS-CoV-2. The potential vaccine epitopes have been rigorously screened for multiple HLA, B-Cell, CTL and helper T lymphocyte epitopes thus augmenting its capability in inducing both humoral and cellular immune responses. Furthermore, it can be co-opted with adjuvant treatment in further enhancing viral disease control. The epitopes were further screened and validated for 100% conservancy with nonoverlapping human proteome thus additionally reducing the chances of autoimmunogenic side effects. The molecular docking of epitopes with HLA alleles were further validated for their mode of binding patterns and analysis of binding energy affinities.

• The December of 2019 witnessed emergence of worldwide outbreak by a novel strain of coronavirus (CoV) termed SARS-CoV-2. • There is no therapeutic or preventive strategy like vaccine developed so far to overcome infection.

• The receptor binding domain of SARS-Cov-2 for any potential vaccine epitopes were explored using immunoinformatics approach. • The B-cell epitopes LFRKSN and SYGFQPT, were found to be highly antigenic. Among T-cell epitopes, the epitope CVADYSVLY and FTNVYADSF were antigenic and exhibited affinity for maximum number of MHC class I alleles.

The T-cell epitopes YRLFRKSNL and VYAWNRKRI displayed affinity for maximum number of MHC class II alleles. The overlapping epitope among B-and T-cells was YRLFRKSNL. • The epitopes were further screened and validated for 100% conservancy with nonoverlapping human proteome thus additionally reducing the chances of autoimmune side effects. • The important conserved residues of BatCoV RaTG13, the Leu-455 and Phe-456 that have been involved in interactions, also demonstrated overlap with epitopes. These residues lay within the B-cell epitope (455-LFRKSN-461) and T-cell epitope (453-YRLFRKSNL-461). • The deployment of these epitopes in potential vaccine against COVID-19 may help in sweeping the COVID- 19 infectious spread.

To view the supplementary data that accompany this paper please visit the journal website at:

www.futuremedicine.com/doi/suppl/10.2217/fvl-2020-0269

Coronavirus latest: WHO officially names disease COVID-19. www.nature.com/articles

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Koch's postulates fulfilled for SARS virus

Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models

Severe acute respiratory syndrome

A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events

The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea

COVID-19) cases statistics

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China

Epidemiology, genetic recombination, and pathogenesis of coronaviruses

Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the Middle East respiratory syndrome

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines

Receptor-binding domain as a target for developing SARS vaccines

CoV spike protein: a key target for antivirals

Harnessing bioinformatics to discover new vaccines

Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach

Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies

Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV

Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach

More evidence emerges that bats may have spread SARS

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

Molecular evolution of human coronavirus genomes

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

Coronavirus receptor switch explained from the stereochemistry of protein-carbohydrate interactions and a single mutation

Computational studies of pandemic 1918 and 2009 H1N1 hemagglutinins bound to avian and human receptor analogs

Molecular mechanism of the enhanced virulence of 2009 pandemic influenza A (H1N1) virus from D222G mutation in the hemagglutinin: a molecular modeling study

Structural analysis of the novel influenza A (H7N9) viral neuraminidase interactions with current approved neuraminidase inhibitors oseltamivir, zanamivir, and peramivir in the presence of mutation R289K

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Picornavirus-receptor interactions

Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses

Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak

Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes

Prediction of MAYV peptide antigens for immunodiagnostic tests by immunoinformatics and molecular dynamics simulations

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development

Antigenic peptide prediction from E6 and E7 oncoproteins of HPV types 16 and 18 for therapeutic vaccine design using immunoinformatics and MD simulation analysis

Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine

Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates

Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus

Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes

SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens

Evaluation of candidate vaccine approaches for MERS-CoV

Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in silico approach applied to emerging infectious diseases

Epitope-based peptide vaccine design and target site depiction against Middle East respiratory syndrome coronavirus: an immune-informatics study

The COVID-19 vaccine development landscape

Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment

VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines

The Immune Epitope Database (IEDB) 3.0

BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes

A semi-empirical method for prediction of antigenic determinants on protein antigens

Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide

Prediction of the secondary structure of proteins from their amino acid sequence

Accuracy of protein flexibility predictions

Improved method for predicting linear B-cell epitopes

ElliPro: a new structure-based tool for the prediction of antibody epitopes

Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction

Gapped sequence alignment using artificial neural networks: application to the MHC class I system

Improved methods for predicting peptide binding affinity to MHC class II molecules

AntiAngioPred: a server for prediction of anti-angiogenic peptides

ClanTox: a classifier of short animal toxins

PEP-FOLD: an online resource for de novo peptide structure prediction

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Ramachandran plot on the web

ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins

QMEAN: a comprehensive scoring function for model quality assessment

MolProbity: more and better reference data for improved all-atom structure validation

Verification of protein structures: patterns of nonbonded atomic interactions

The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes

PDBsum: structural summaries of PDB entries

Origin and evolution of pathogenic coronaviruses

Virus entry: open sesame

MHC superfamily structure and the immune system

A recurrent mutation in anaplastic lymphoma kinase with distinct neoepitope conformations

Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins

Covid-19: denmark to kill 17 million minks over mutation that could undermine vaccine effort

Sixteen novel lineages of SARS-CoV-2 in South Africa

The cytokine storm of severe influenza and development of immunomodulatory therapy

Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission

What have we learned about Middle East respiratory syndrome coronavirus emergence in humans? A systematic literature review

Dampened STING-dependent interferon activation in bats